Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study.
Savas P, Lo LL, Luen SJ, Blackley EF, Callahan J, Moodie K, van Geelen CT, Ko YA, Weng CF, Wein L, Silva MJ, Bujak AZ, Yeung MM, Ftouni S, Hicks RJ, Francis PA, Lee CK, Dawson SJ, Loi S. Savas P, et al. Among authors: ko ya. Cancer Discov. 2022 Sep 2;12(9):2058-2073. doi: 10.1158/2159-8290.CD-21-1696. Cancer Discov. 2022. PMID: 35771551 Clinical Trial.
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
Zivanovic Bujak A, Weng CF, Silva MJ, Yeung M, Lo L, Ftouni S, Litchfield C, Ko YA, Kuykhoven K, Van Geelen C, Chandrashekar S, Dawson MA, Loi S, Wong SQ, Dawson SJ. Zivanovic Bujak A, et al. Among authors: ko ya. PLoS Med. 2020 Oct 1;17(10):e1003363. doi: 10.1371/journal.pmed.1003363. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33001984 Free PMC article.
Evaluation of two population screening programmes for BRCA1/2 founder mutations in the Australian Jewish community: a protocol paper.
Cousens NE, Tiller J, Meiser B, Barlow-Stewart K, Rowley S, Ko YA, Mahale S, Campbell IG, Kaur R, Bankier A, Burnett L, Jacobs C, James PA, Trainer A, Neil S, Delatycki MB, Andrews L. Cousens NE, et al. Among authors: ko ya. BMJ Open. 2021 Jun 25;11(6):e041186. doi: 10.1136/bmjopen-2020-041186. BMJ Open. 2021. PMID: 34172541 Free PMC article.
Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.
Tiller JM, Cousens NE, Kaur R, Rowley S, Ko YA, Mahale S, Bankier A, Meiser B, Barlow-Stewart K, Burnett L, Jacobs C, James P, Trainer A, Neil S, Campbell IG, Andrews L, Delatycki M. Tiller JM, et al. Among authors: ko ya. J Med Genet. 2023 Mar;60(3):265-273. doi: 10.1136/jmedgenet-2022-108519. Epub 2022 Jun 3. J Med Genet. 2023. PMID: 36763037
N terminal pro-brain natriuretic peptide level and benefits of chronic total occlusion revascularization.
Gold DA, Sandesara PB, Jain V, Gold ME, Vatsa N, Desai SR, Hassan ME, Yuan C, Ko YA, Liu C, Ejaz K, Alvi Z, Alkhoder A, Rahbar A, Murtagh G, Varounis C, Jaber WA, Nicholson WJ, Quyyumi AA. Gold DA, et al. Among authors: ko ya. Int J Cardiol. 2024 May 21:132196. doi: 10.1016/j.ijcard.2024.132196. Online ahead of print. Int J Cardiol. 2024. PMID: 38782069
Racial differences in fibromuscular dysplasia.
Martinez A, Steinberg RS, Okoh A, Ko YA, Wells B. Martinez A, et al. Among authors: ko ya. Vasc Med. 2024 Apr 30:1358863X241239869. doi: 10.1177/1358863X241239869. Online ahead of print. Vasc Med. 2024. PMID: 38689448 No abstract available.
Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.
Gold DA, Sandesara PB, Kindya B, Gold ME, Jain V, Vatsa N, Desai SR, Yadalam A, Razavi A, Elhage Hassan M, Ko YA, Liu C, Alkhoder A, Rahbar A, Hossain MS, Waller EK, Jaber WA, Nicholson WJ, Quyyumi AA. Gold DA, et al. Among authors: ko ya. Int J Cardiol. 2024 Jul 15;407:132104. doi: 10.1016/j.ijcard.2024.132104. Epub 2024 Apr 25. Int J Cardiol. 2024. PMID: 38677332
226 results